World’s first approved allogeneic cell therapy for corneal endothelial diseaseProf. Shigeru Kinoshita, M.D., cell therapy inventor, successfully treats first patients
SEATTLE & CAMBRIDGE, Mass. & TOKYO–BUSINESS WIRE–Aurion Biotech, whose mission is to restore vision to millions of patients with life-changing regenerative therapies, today announced the commercial launch of Vyznova® (generic name: neltependocel) in Japan, for the treatment of bullous keratopathy of the cornea. The…
Read More…